Continued Disappointment
Nu Skin (NUS) continues to disapoint qtr after qtr, thus I will sell it from the Growth Portfolio.
Nu Skin (NUS) continues to disapoint qtr after qtr, thus I will sell it from the Growth Portfolio.
Nu Skin (NUS) looks to have turned the corner, and new products expected later this year could be catalysts for NUS.
Things couldn’t be worse for Nu Skin (NUS) which is why I feel the stock has bottomed.
Nu Skin (NUS) is having troubles, but I feel this shall pass and I think NUS offers great potential for investors willing to wait it out.
I do believe Nu Skin’s (NUS) profit growth will go back to normal now that the China investigation is behind it.
China’s regulators was a huge cloud hanging over Nu Skin (NUS). Now the cloud has lifted and I’m buying NUS,
Nu Skin (NUS) was under pressure because of China’s regulators. Now the fine is levied and NUS can rise again.
Anti-aging skin cream specialist Nu Skin (NUS) is the best stock I do not own. I see big things for NUS in 2014, here’s my analysis:
Nu Skin (NUS) is clearly a top stock. But now its jumped from $ 59 to $79 and is very extended. Let’s take a look at where NUS stands now, and if we should get some while its high.
Shares of multi-level marketing companies (MLM) have been clobbered as they are being seen as pyramid schemes. But stock like Nu Skin (NUS) fit the mold.
Nu Skin (NUS) is a bargain. The P/E is only 13 and the company is expected to grow 15% a year plus pay a 2% dividend. But there’s a catch…
Today I will sell Nu Skin (NUS) to purchase more shares of Apple (AAPL). I need the cash and Nu Skin is at the bottom of my Growth Portfolio Power Rankings.
Nu Skin (NUS) had serious momentum last quarter, now it doesn’t. After topping at 20 times earnings, the stock has corrected, and is now undervalued.
It could be said my article on Nu Skin (NUS) Sunday sparked a rally — the stock’s gone from $54 to $59. Today I will buy NUS for the Growth Portfolio.
Nu Skin (NUS), a company that makes anti-aging products, broke out yesterday. To a 52-week and all time high. NUS fits the mold I look for, so let’s take a look at the stock.